Press release
Pneumococcal Vaccines Market is anticipated to grow at a CAGR of 7.5% by 2026: Top key players Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc
Healthcare facilities are looking forward to expand their facilities with advanced technologies to create innovative and cost-effective solutions to address barriers to universal vaccinationFor instance, in April 2016, Glaxo Smith Kline (GSK) and Vodafone collaborated to provide smartphones with an app to various healthcare facilities in northern Mozambique, Africa for a period of one year. The program received funds from GAVI and United States Agency for International Development (USAID) under mVacciNation pilot program. The app enables these healthcare facilities to report regularly on vaccine stock levels and refrigerator temperatures, thereby improving critical supply chain and cold chain management. Furthermore, it helps health workers to register patients, view their vaccination histories, and also allows to send reminders to registered patients for their next vaccination.
Get Exclusive Sample Copy @ www.coherentmarketinsights.com/insight/request-sample/2295
Increasing collaborations among key players to develop and introduce new pneumococcal vaccines and ongoing clinical trial studies on pneumococcal vaccine are expected to drive growth of the pneumococcal vaccines market. For instance, in April 2018, Merck & Co, Inc. initiated two Phase III studies of PCV-15 (V114), an investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease.
Furthermore, in February 2017, Astellas Pharma Inc. and Affinivax, Inc. signed an exclusive worldwide license agreement to develop and commercialize a vaccine targeting Streptococcus pneumoniae. This partnership would utilize Affinivax’s proprietary vaccine technology platform – Multiple Antigen Presenting System (MAPS) to develop a novel vaccine.
Key players operating in the pneumococcal vaccines market include, Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc.
Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns. Therefore, vendors are focused on joining Advance Market Commitment (AMC), an innovative financing program. Under AMC, international agencies pay a premium above the incremental production cost for initial doses sold to emerging economies in exchange of continuous supply of vaccines from vendors at sustainable prices for long term.
In 2010, Pfizer entered into the AMC program and agreed to supply 300 Mn doses of PCV13 for pneumococcal disease. Subsequently, Pfizer entered into two additional agreements with the AMC expanding its commitment with an additional 440 Mn doses, for a total commitment of 740 Mn doses of PCV13 vaccine until 2025.
Download PDF Brochure of This Business Research Report: www.coherentmarketinsights.com/insight/request-pdf/2295
Moreover, in 2015, Pfizer reduced prices of four new dose vial presentations of PCV13, which was expected to be introduced under the AMC program in 2016. The prices were reduced by 20% per-dose i.e., from US$ 3.30 per dose to US$ 3.10 per dose.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,, #3200, Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumococcal Vaccines Market is anticipated to grow at a CAGR of 7.5% by 2026: Top key players Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc here
News-ID: 1627789 • Views: …
More Releases from Coherent Market Insights,Inc

Incredible Growth of +22.1% CAGR for Nanopharmaceuticals Market is Thriving Worl …
Key players in the market are focused on research and development of nanopharmaceuticals in order to develop novel products to address the critical unmet needs of patients. According to the P&T Community Journal, December 2017, DTXSPL8783, dendrimer for cancer treatment is being investigated, which is in clinical trials of phase 1 study, for patients with advanced cancer.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2485
Similarly, Vivagel developed by Starpharma, is in phase 3 clinical…

Childhood Absence Epilepsy Treatment Market Growing at a CAGR of 5.4% by 2026, F …
According to various studies published by the National Center for Biotechnology Information and recent recommendation by the National Institute for Health and Care Excellence (NICE), 2018, Ethosuximide should be considered as a first choice of treatment, followed by Valproate and Lamotrigine. Moreover, various manufacturers such as Insys Therapeutics (Cannabidiol) and Cavion, Inc. (CX-8998) have drugs in phase II stage in clinical trials and these therapies are expected to be launched…

Ureteral Stents Market Global Outlook 2018-2026 | Leading Vendors Applied Medica …
New designs such as a helically-cut ureteral stent is aimed to stretch and conform the ureter. Drug-eluting stents with an antimicrobial property are designed to reduce bacterial adherence to ureteral stents. Furthermore, bioabsorbable stents are designed to reduce infection and prevent the forgotten stent syndrome. In June 2018, HydrUStent, a startup based at the University of Minho in Portugal, announced its research on developing a ureteral stent made from a…

Newborn Screening Market Studied by Focusing on Major Companies: Agilent Technol …
Newborn screening tests look for developmental, metabolic, and genetic disorders in infants. It allows steps to be taken before development of symptoms. Although, majority of these illnesses are very rare, they can be treated with early diagnosis. Newborn screening includes over 30 conditions and illnesses. Increasing awareness among parents for disease screening is a major factor driving newborn screening market growth. Furthermore, various government and non-government organizations are actively focused…
More Releases for AMC
Global AMC Filters for Semiconductor Market Analysis (2024-2029)
On July 23, 2024, LPI (LP Information) released the report titled "Global AMC Filters for Semiconductor Market Growth (Status and Outlook) 2024-2030." This report provides a comprehensive analysis of the global AMC Filters for Semiconductor landscape, with a focus on key trends related to product segmentation, company establishment, revenue and market share, recent developments, and merger and acquisition activities. Additionally, the report delves into the strategies of global leading companies,…
Lokekey Productions Clarifies Misleading Claims Regarding AMC Theaters Collabora …
Chicago, IL - Lokekey Productions [http://www.lokekey.com], a prominent independent film production company based in Chicago, is addressing recent rumors suggesting that AMC Theaters declined a partnership with the company. These claims, which have been circulating online, are entirely unfounded, and Lokekey Productions is setting the record straight to avoid any misunderstandings.
Image: https://www.abnewswire.com/uploads/c0244cf96ada5329e532a7f6c1ad74d4.png
The Origins and Impact of the Rumors
Over the past 24 hours, Lokekey Productions has received numerous inquiries from fans,…
Investigation announced for Long-Term Investors in shares of AMC Entertainment H …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at AMC Entertainment Holdings Inc.
Investors who purchased shares of AMC Entertainment Holdings Inc (NYSE: AMC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain AMC Entertainment Holdings Inc (directors breached their fiduciary duties and caused damage to the company…
AMC Entertainment Holdings Inc (NYSE: AMC) Investor Notice: Lawsuit filed agains …
Investors in shares of AMC Entertainment Holdings Inc (NYSE: AMC) filed a lawsuit against certain directors of AMC Entertainment Holdings Inc over alleged wrongdoing in connection with the proposed stock increase.
Investors who purchased shares of AMC Entertainment Holdings Inc (NYSE: AMC) and currently hold any of those: AMC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
In August 2022 , the…
Dale play premieres at AMC theatre in NY
With the presence of its directors, actors and cinema lovers, NYC Latin Media film company held the premiere gala of its most recent film Dale Play, by the Dominican director Walmy De La Cruz at the Lowes AMC facilities in Manhattan.
The film, produced by Raquel Ureña and Steve Sanchez, and was shot entirely between Connecticut and New York.
"Dale Play" stars the Dominican actor Manny Gomez and the puertorican actress…
AMC Entertainment Holdings Inc (NYSE: AMC) Investor Alert: Investigation over po …
An investigation on behalf of current long-term investors in shares of AMC Entertainment Holdings Inc (NYSE: AMC) was announced over potential breaches of fiduciary duties by certain officers and directors at AMC Entertainment Holdings Inc (NYSE: AMC.
Investors who purchased shares of AMC Entertainment Holdings Inc (NYSE: AMC) and currently hold any of those AMC Entertainment Holdings Inc (NYSE: AMC shares have certain options and should contact the Shareholders Foundation at…